Sun Pharma chief expects Ranbaxy deal to be closed by mid-Feb
Drug major Sun Pharma's top executive Dilip S Shanghvi expects the USD 4-billion Ranbaxy deal to be concluded by middle of next month while stating that the key challenge before the combined entity would be to rebuild the confidence of health regulators.
Jan 25, 2015, 11:14 AM ISTIndia wants its officials during FDA inspections at drug units
Perturbed by Indian drug-makers frequently running into overseas regulatory problems, the government has requested the US health watchdog FDA to allow its officials during inspections of domestic pharma units.
Jan 11, 2015, 12:13 PM IST